Mural oncology to present at the td cowen 45th annual health care conference

Waltham, mass and dublin, feb. 18, 2025 (globe newswire) -- mural oncology plc (nasdaq: mura), a clinical-stage immuno-oncology company developing novel, investigational engineered therapies targeting cytokine pathways, today announced that ceo caroline loew, ph.d., will present at the td cowen 45th annual health care conference on march 4, 2025 and 3:10 p.m. et. a live webcast of the presentation will be available at https://ir.muraloncology.com/events-and-presentations. a replay of the webcast will be archived and available following the event.
COWN Ratings Summary
Quant
COWN Quant Ranking
Sector
Industry
Quant Rating
Quant Score